Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro. [electronic resource]
Producer: 20170522Description: 135-145 p. digitalISSN:- 1479-6805
- ACTH-Secreting Pituitary Adenoma -- drug therapy
- Adenoma -- drug therapy
- Antineoplastic Agents, Hormonal -- adverse effects
- Calcium Signaling -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Drug Resistance, Neoplasm
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Growth Hormone-Secreting Pituitary Adenoma -- drug therapy
- Humans
- Male
- Neoplasm Proteins -- agonists
- Octreotide -- adverse effects
- Pituitary Gland -- drug effects
- Pituitary Neoplasms -- drug therapy
- Prolactinoma -- drug therapy
- Protein Isoforms -- agonists
- Receptors, Somatostatin -- agonists
- Somatostatin -- adverse effects
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.